Abstract
To compare the efficacy of hepatic resection (HR) and transarterial chemoembolization (TACE) for patients with solitary huge (≥ 10 cm) hepatocellular carcinoma (HCC). Records were retrospectively analyzed of 247 patients with solitary huge HCC, comprising 180 treated by HR and 67 by TACE. Long-term overall survival (OS) was compared between the two groups using the Kaplan-Meier method, and independent predictors of survival were identified by multivariate analysis. These analyses were performed using all patients in both groups and/or 61 pairs of propensity score-matched patients from the two groups. OS at 5 years was significantly higher in the HR group than the TACE group, across all patients (P = 0.002) and across propensity score-matched pairs (36.4% vs 18.2%, P = 0.039). The two groups showed similar postoperative mortality and morbidity. Multivariate analysis identified alpha-fetoprotein ≥ 400 ng/mL, presence of vascular invasion and TACE treatment as independent predictors of poor OS. Our findings suggest that HR can be safe and more effective than TACE for patients with solitary huge HCC.
References
Sep 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Nov 5, 1998·Statistics in Medicine·R B D'Agostino
Mar 15, 2002·Surgery·Shuichi FukudaShigeaki Aoyagi
Oct 31, 2003·Journal of the American College of Surgeons·King-Tong MokYu-Chia Chen
Oct 26, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C B HsiehJ C Yu
Jan 6, 2006·Alimentary Pharmacology & Therapeutics·Y-H HuangS-D Lee
Dec 25, 2008·Annals of Surgery·Lian-Yue YangFan Wu
Mar 10, 2009·American Journal of Surgery·Gi Hong ChoiWoo Jung Lee
Mar 11, 2010·Journal of Clinical Gastroenterology·Peter FerenciUNKNOWN World Gastroenterology Organization
Dec 9, 2010·The Oncologist·Alan P VenookLaura Ladrón de Guevara
Jan 29, 2011·Radiology·Goh Eun ChungYoon Jun Kim
May 15, 2012·Hepato-gastroenterology·Tao XiMeng-chao Wu
Aug 21, 2012·Journal of Surgical Oncology·Brian ShragerSpiros Hiotis
Nov 29, 2012·World Journal of Surgery·Pierre AllemannNermin Halkic
May 15, 2013·World Journal of Surgery·Lianyue YangZhijun Zeng
Jul 23, 2013·PloS One·Jian-Hong ZhongLe-Qun Li
Oct 8, 2013·Annals of Surgery·Jian-hong ZhongLe-qun Li
Apr 11, 2014·Scandinavian Journal of Gastroenterology·Jian-Hong ZhongLe-Qun Li
Jan 27, 2015·Medicine·Jian-Hong ZhongLe-Qun Li
Citations
Feb 1, 2018·Medicine·Lei WangJingfeng Liu
Nov 8, 2017·Integrative Cancer Therapies·Yue-Meng WanXi-Nan Wu
Jan 11, 2019·Internal Medicine·Masashi FujitaHiromasa Ohira
Aug 4, 2016·Oncotarget·Hong In YoonJinsil Seong
Feb 12, 2017·Journal of Gastroenterology and Hepatology·Martha M KirsteinArndt Vogel
Nov 20, 2016·Medicine·Di LongSen Zhang
Aug 30, 2016·World Journal of Gastroenterology : WJG·Jeong Il Yu, Hee Chul Park
Mar 26, 2019·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Shiro MiyayamaKazuo Notsumata
Jan 9, 2021·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Zixiang ChenFubao Liu
Jan 19, 2021·Hepatobiliary & Pancreatic Diseases International : HBPD INT·Han WangWen-Ming Cong
Feb 26, 2021·Scientific Reports·A BogdanovicD Galun
Apr 1, 2021·World Journal of Surgical Oncology·Zhenfeng DengZhang Wen
Dec 22, 2020·Hepatobiliary & Pancreatic Diseases International : HBPD INT·Andrea ChiericiAntonio Facciorusso
Aug 28, 2021·Life·Gun Ha KimDong Il Gwon
Dec 9, 2021·Future Oncology·Yongheng DengLiang Ma